Because of its role(s) in immune response, it has been suggested that NEAT1 could be used as a therapeutic target for inflammatory and autoimmune diseases (Imamura et al., 2014; Zhang et al., 2016; Huang et al., 2017; Pandey et al., 2017; Prinz et al., 2019; Zhang et al., 2019). Here, NEAT1 is linked to autoimmune disease.